Caribou Biosciences, Inc. 8-K Filing: Key Insights and Securities Info

$CRBU
Form 8-K
Filed on: 2025-01-13
Source
Caribou Biosciences, Inc. 8-K Filing: Key Insights and Securities Info

Based on the provided section of the financial report, here are the key insights:

  1. Company Information:
  • Name: Caribou Biosciences, Inc.
  • CIK Number: 0001619856
  • State of Incorporation: Delaware (DE)
  • Tax ID: 45-3728228
  • Address: 2929 7th Street, Suite 105, Berkeley, CA 94710
  • Phone Number: 510-982-6030
  1. Filing Details:
  • Filing Type: Form 8-K
  • Filing Date: January 12, 2025
  • Period Covered: January 12, 2025
  • SEC File Number: 001-40631
  1. Securities Information:
  • Common Stock: Par value of $0.0001 per share
  • Ticker Symbol: CRBU
  • Exchange: NASDAQ
  1. XML and XBRL Information:
  • The report is formatted in XBRL (eXtensible Business Reporting Language) for regulatory purposes, which allows for easier data analysis and interpretation.
  • A schema reference is provided, indicating the specific XBRL definitions used in this filing.

Summary:

This section of the report provides essential details about Caribou Biosciences, Inc., including its basic corporate information, the nature of the filing (Form 8-K), and its securities listed on NASDAQ. The filing is structured in XBRL format, which is important for compliance and makes it easier for investors and analysts to access the data.